Vax Before Cancer

 / September 29th, 2022

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Jun 23 • 1:13 pm CDT
Massachusetts-based VBI Vaccines Inc. announced yesterday that the U.S. FDA granted Orphan Drug Designation for VBI-1901, a bivalent vaccine candidate for the treatment of glioblastoma (GBM). VBI-1901 is a novel cancer vaccine immunotherapeutic candidate developed using...
May 17 • 9:17 am CDT
The U.S. CDC recently published updated COVID-19 testing suggestions when traveling and confirmed an at-home test solution available for free. As of May 16, 2022, the CDC's website encourages anyone planning to travel to get tested...
Mar 8 • 7:15 am CST
The Annals of Internal Medicine published Original Research on March 1, 2022, 'Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort,' funded by the National Cancer Institute. Mammography screening can lead to overdiagnosis—that is,...
Feb 21 • 4:33 pm CST
Positive topline results from the pivotal DESTINY-Breast04 phase 3 clinical trial announced today showed ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in both progression-free survival (PFS) and overall survival (OS) in patients...
Feb 18 • 1:47 pm CST
Cambridge-based Moderna, Inc. today announced that it is expanding its mRNA vaccine pipeline. One of the new vaccines is a checkpoint cancer vaccine candidate, mRNA-4359. Moderna's mRNA-4359 expresses Indoleamine 2,3-dioxygenase and programmed death-ligand 1 antigens. Moderna...

For more articles, try our search.